Garnet Equity Capital Holdings’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-100,000
Closed -$3.14M 30
2023
Q3
$3.14M Buy
+100,000
New +$3.15M 1.78% 17
2022
Q4
Sell
-476
Closed -$6K 31
2022
Q3
$6K Buy
+476
New +$19.8K 0.01% 28
2022
Q2
Sell
-65,000
Closed -$88K 38
2022
Q1
$88K Buy
+65,000
New +$3.56M 0.09% 33

Other funds holding ATEX

Garnet Equity Capital Holdings's ATEX Position: Q1 2026 in Review

Garnet Equity Capital Holdings reduced its Anterix (ATEX) stake by 14% in Q1 2026, selling an estimated $1.71M and leaving 343,496 shares worth $13.1M. The position accounts for 2.04% of the portfolio, ranked #7.

Garnet Equity Capital Holdings first reported a position in ATEX in Q3 2020 and has held it in 23 quarters since. The position peaked at $14.2M in Q1 2025. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Garnet Equity Capital Holdings held 343,496 shares of Anterix worth $13.1M as of Q1 2026.
  • Garnet Equity Capital Holdings sold 53,899 Anterix shares in Q1 2026, an estimated $1.71M.
  • Anterix made up 2.04% of Garnet Equity Capital Holdings's portfolio in Q1 2026, its #7 holding.
  • Garnet Equity Capital Holdings first reported a position in Anterix in Q3 2020 and has held it in 23 quarters since.
  • Garnet Equity Capital Holdings's Anterix position peaked at $14.2M in Q1 2025.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Garnet Equity Capital Holdings's 13F filing for Q1 2026, filed 15 May 2026.